dc.contributor.advisor | Afrose, Dr. Afrina | |
dc.contributor.author | Sultana, Sadia | |
dc.date.accessioned | 2023-05-16T06:24:23Z | |
dc.date.available | 2023-05-16T06:24:23Z | |
dc.date.copyright | 2022 | |
dc.date.issued | 2022-01 | |
dc.identifier.other | ID: 18146093 | |
dc.identifier.uri | http://hdl.handle.net/10361/18299 | |
dc.description | This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022. | en_US |
dc.description | Cataloged from PDF version of thesis. | |
dc.description | Includes bibliographical references (pages 46-55). | |
dc.description.abstract | Coronavirus disease 2019 also known as COVID-19, is an acute respiratory condition (Severe
acute respiratory syndrome coronavirus 2 or SARS-CoV-2) caused by a novel coronavirus that
was discovered for the first time in Wuhan, China’s Hubei Province, during a respiratory illness
outbreak. The World Health Organization declared the COVID-19 pandemic a worldwide
health emergency. The aim of this article is to evaluate the drugs that are currently used for the
COVID 19 treatment and to outline the mechanism of actions and therapeutic efficacy of these
drugs along with the comparison between them. This review has been conducted with a
comprehensive literature analysis of clinical characteristics and therapies of the novel COVID 19 using internet databases with the recent relevant publications and research. Remdesivir,
dexamethasone and amantadine are more effective than other drugs for people who are
hospitalized with COVID-19 and need supplemental oxygen or have a higher risk of serious
illness. | en_US |
dc.description.statementofresponsibility | Sadia Sultana | |
dc.format.extent | 55 pages | |
dc.language.iso | en | en_US |
dc.publisher | Brac University | en_US |
dc.rights | Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. | |
dc.subject | Remdesivir | en_US |
dc.subject | Hydroxychloroquine and chloroquine | en_US |
dc.subject | Azithromycin | en_US |
dc.subject | Dexamethasone | en_US |
dc.subject | COVID 19 | en_US |
dc.subject.lcsh | COVID-19 (Disease) -- Treatment | |
dc.title | Medications used for covid-19 treatment and a comparison of their mechanism of action and therapeutic efficacy | en_US |
dc.type | Thesis | en_US |
dc.contributor.department | Department of Pharmacy, Brac University | |
dc.description.degree | B. Pharmacy | |